|Home | About | Journals | Submit | Contact Us | Français|
Kitada M, Shin-ichi T, Konishi K et al. Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner. BMJ Open Diabetes Res Care 2017;5:e000391. doi:10.1136/bmjdrc-2017-000391.
The funding statement has been amended to: This work was financially supported by a grant from the Kidney Foundation, Japan and SANWA KAGAKU KENKYUSHO CO, LTD to DK.